Displaying 1 - 50 of 14215 results
Released Company Title Industry Topic
22 Jan 2024
22:02 CET
OXURION Oxurion Announces New Strategic Orientation to De-risk and Diversify 20103010 Biotechnology -
22 Jan 2024
20:03 CET
ONWARD MEDICAL ONWARD® to Participate in Basel Healthtech Conference 2024 20101025 Health Services -
22 Jan 2024
18:05 CET
GBL GBL - Transacties op GBL-aandelen 22-01-2024 30202000 Diversified Financial Services Other financial transaction
22 Jan 2024
18:04 CET
GBL GBL - Transactions sur actions propres 22-01-2024 30202000 Diversified Financial Services Other financial transaction
22 Jan 2024
18:03 CET
GBL GBL - Transactions on GBL shares 22-01-2024 30202000 Diversified Financial Services Other financial transaction
22 Jan 2024
18:00 CET
BIOTALYS NV Biotalys Notice of Full Year 2023 Results and Business Highlights 55201015 Fertilizers -
22 Jan 2024
17:45 CET
KINEPOLIS GROUP Mise à jour concernant le programme de rachat d'actions propres (22 janvier 2024) 40301010 Entertainment Corporate life
22 Jan 2024
17:45 CET
KINEPOLIS GROUP Update inkoopprogramma eigen aandelen (22 januari 2024) 40301010 Entertainment Corporate life
22 Jan 2024
17:45 CET
KINEPOLIS GROUP Update share buyback program (22 January 2024) 40301010 Entertainment Corporate life
22 Jan 2024
17:40 CET
AGEAS Nieuwe samenstelling van Ageas’ Executive Committee 30301010 Life Insurance -
22 Jan 2024
17:40 CET
AGEAS New composition of Ageas’s Executive Committee 30301010 Life Insurance -
22 Jan 2024
17:40 CET
AGEAS Nouvelle composition de l’Executive Committee d'Ageas 30301010 Life Insurance -
22 Jan 2024
15:12 CET
KBC Redemption notice to the holders of the notes 30101010 Banks Other subject
22 Jan 2024
07:22 CET
JENSEN-GROUP Inkoop eigen aandelen - wekelijkse update 50204000 Machinery: Industrial Other subject
22 Jan 2024
07:21 CET
JENSEN-GROUP Share buyback – weekly update 50204000 Machinery: Industrial Other subject
19 Jan 2024
19:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas 20103010 Biotechnology -
19 Jan 2024
18:48 CET
ONWARD MEDICAL ONWARD® to Participate in Degroof Petercam Healthcare Conference 20101025 Health Services -
19 Jan 2024
18:00 CET
VASTNED BELGIUM Vastned Belgium: Refinancement des lignes de crédit existantes 35102045 Retail REITs Corporate life
19 Jan 2024
18:00 CET
VASTNED BELGIUM Vastned Belgium: Herfinanciering van de bestaande kredietlijnen 35102045 Retail REITs Corporate life
19 Jan 2024
18:00 CET
VASTNED BELGIUM Vastned Belgium: Refinancing of the existing credit lines 35102045 Retail REITs Corporate life
19 Jan 2024
08:15 CET
BEKAERT Bekaert - Mise à jour relative au Programme de Rachat d’Actions 55102010 Iron and Steel Legal
19 Jan 2024
08:15 CET
BEKAERT Bekaert - Update over het Inkoopprogramma van Eigen Aandelen 55102010 Iron and Steel Legal
19 Jan 2024
08:15 CET
BEKAERT Bekaert - Update on the Share Buyback Program 55102010 Iron and Steel Legal
18 Jan 2024
19:00 CET
HYLORIS Hyloris Elargit son Portefeuille de Produits avec un Nouveau Produit Candidat pour le Lichen Scléreux Vulvaire (LSV) 20103010 Biotechnology Products and services
18 Jan 2024
19:00 CET
HYLORIS Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS) 20103010 Biotechnology Products and services
18 Jan 2024
18:00 CET
VAN DE VELDE VAN DE VELDE : acquisition of treasury shares 40204020 Clothing and Accessories Other subject
18 Jan 2024
18:00 CET
VAN DE VELDE VAN DE VELDE : inkoop eigen aandelen 40204020 Clothing and Accessories Other subject
18 Jan 2024
17:52 CET
LOTUS BAKERIES Disposal of treasury shares 45102020 Food Products Other subject
18 Jan 2024
17:45 CET
DMS IMAGING S.A. DMS Imaging : Chiffre d'affaires annuel 2023 : +15% à 40,5 M EUR . 20103010 Biotechnology Sales, Income
18 Jan 2024
07:30 CET
ONWARD MEDICAL ONWARD® Announces Start of HemON NL Clinical Study 20101025 Health Services -
18 Jan 2024
07:00 CET
ARGENX SE argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis 20103010 Biotechnology Other subject
17 Jan 2024
22:05 CET
NYXOAH SA Nyxoah Announces 2024 Strategic Priorities 20102010 Medical Equipment Other subject
17 Jan 2024
22:05 CET
NYXOAH SA Nyxoah Annonce ses Priorités Stratégiques pour 2024 20102010 Medical Equipment Other subject
17 Jan 2024
19:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology -
17 Jan 2024
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification 35102030 Office REITs Change in Capital
17 Jan 2024
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification 35102030 Office REITs Change in Capital
17 Jan 2024
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification 35102030 Office REITs Change in Capital
17 Jan 2024
07:30 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG 35102030 Office REITs Takeover bids
17 Jan 2024
07:30 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG 35102030 Office REITs Takeover bids
17 Jan 2024
07:30 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG 35102030 Office REITs Takeover bids
16 Jan 2024
22:01 CET
CELYAD ONCOLOGY Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024 20103010 Biotechnology Corporate life
16 Jan 2024
22:01 CET
CELYAD ONCOLOGY Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook 20103010 Biotechnology Corporate life
16 Jan 2024
19:30 CET
HYLORIS Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML) 20103010 Biotechnology Products and services
16 Jan 2024
19:30 CET
HYLORIS La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA) 20103010 Biotechnology Products and services
16 Jan 2024
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification 35102030 Office REITs Change in Capital
16 Jan 2024
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification 35102030 Office REITs Change in Capital
16 Jan 2024
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification 35102030 Office REITs Change in Capital
16 Jan 2024
08:30 CET
CIE BOIS SAUVAGE Cie du Bois Sauvage : Rachat d’actions propres – semaine du 08/01/2024 au 12/01/2024 30202010 Asset Managers and Custodians Other subject
16 Jan 2024
08:30 CET
CIE BOIS SAUVAGE Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 08/01/2024 tot 12/01/2024 30202010 Asset Managers and Custodians Other subject
16 Jan 2024
08:30 CET
CIE BOIS SAUVAGE Cie du Bois Sauvage: Buy back of own shares – week from 08/01/2024 to 12/01/2024 30202010 Asset Managers and Custodians Other subject